openPR Logo
Press release

OTC Perspectives Announces 2010 Ad Awards Finalists

03-29-2010 10:39 AM CET | Health & Medicine

Press release from: DTC Perspectives, Inc.

FLORHAM PARK, N.J. [March 22, 2010] – OTC Perspectives, Inc., the leading conference, training and publishing company for over-the-counter (OTC) marketing, today announced the finalists for the 2nd annual OTC National Advertising Awards, presented in conjunction with the OTC National Conference, May 18-19, in Philadelphia, PA. The award winners will be announced at the OTC National Advertising Awards reception, sponsored by HealthCentral, on the night of May l8, at the Penn’s Landing Hyatt in Philadelphia.

Leading healthcare companies and brands will be honored at the awards reception which will showcase the best OTC marketing and advertising campaigns with Gold, Silver, and Bronze awards across eight categories. Brands among the finalist include Vicks, Pepcid, Pepto Bismol, Claritin, Triaminic, Durex, Robitussin, and Zyrtec. For a complete list of award finalists, please visit the 2010 OTC Advertising Awards Website.

"Delegates attending the OTC National Conference will determine the winners for Best Branded TV and Best Branded Print Campaign award," announced Bob Ehrlich, CEO of DTC Perspectives, and OTC National Conference Chairman. "Independent expert judging panels will determine award winners for the other categories."

The OTC National Conference is designed to provide OTC marketers with an opportunity to learn from industry thought leaders and discuss the latest innovations in the industry. Attendees will benefit from case studies, new market research, media & marketing gurus and networking opportunities and this year will include keynote addresses by Jeff Arnold, Founder of Web MD and Chairman of Sharecare; Dr. Jan-Benedict Steenkamp, author of the book “How to Meet the Store Brand Challenge;” and Jim Joseph, President of Lippe Taylor Brand Communications and author of the new book “The Experience Effect.” For conference registration, please visit our Website, www.OTCPerspectives.com or call Debra Sander at (973) 377-2106 ex 221.

OTC Perspectives, Inc. is the leading conference, training and publishing company specializing in the analysis of over-the-counter (OTC) healthcare product marketing. It is our goal to serve as the premier information exchange forum for OTC marketing thought leaders with the publication of OTC Perspectives magazine as well as through attendance at our Conference Series.

OTC Perspectives, Inc. is the leading conference, training and publishing company specializing in the analysis of over-the-counter (OTC) healthcare product marketing. It is our goal to serve as the premier information exchange forum for OTC marketing thought leaders with the publication of OTC Perspectives magazine as well as through attendance at our Conference Series.

30 Columbia Turnpike, Suite 205
Florham Park, NJ 07932
973-377-2106 (Phone)
973-377-1106 (Fax)

General Inquires
Debra Sander
Office Coordinator
(973) 377-2106 x221
Debra@dtcperspectives.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release OTC Perspectives Announces 2010 Ad Awards Finalists here

News-ID: 124992 • Views: 1172

More Releases for OTC

Investigation for Long-Term Investors in shares of Volkswagen AG (OTC: VWAGY / O …
An investigation on behalf of current long-term investors in shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) was announced over potential breaches of fiduciary duties by certain officers and directors at Volkswagen AG. Investors who purchased shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) and currently hold any of those Volkswagen AG shares have certain options and should contact the Shareholders Foundation at
OTC: VWAGY / OTC: VLKAF / OTC: VWAPY Shareholder Notice: Update in Lawsuit again …
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Volkswagen AG (OTC: VWAGY) (OTC: VWAPY) shares. Investors, who purchased shares of Volkswagen AG (OTC: VWAGY) (OTC: VLKAF) (OTC: VWAPY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On September 25, 2015, a lawsuit was filed against Volkswagen AG (alleged securities laws violations. The plaintiff claimed that the defendants
Foods Matrix Inc. Exploring OTC Markets Listing
Foods Matrix Inc. (FMI), a US based food processing startup is exploring options to list on the OTC Markets. FMI is in talks to acquire a distressed food processing unit in the state of Punjab, India for US $3 million. The deal may be sealed by the end of November, 2018, post completion of the ongoing due diligence. FMI may initially quote on the pink sheet segment of the OTC Markets
03-14-2018 | Health & Medicine
Fact.MR
OTC Analgesics Market Report 2017-22: Pharmacy to Remain the Most Lucrative OTC …
A fresh study, covering “OTC Analgesics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make
11-28-2017 | Health & Medicine
Fact.MR
7 Key Projections for OTC Analgesics Market
The global OTC analgesics market is projected to register an above-average CAGR during 2017 to 2022. Global sales of OTC analgesics is estimated to account for nearly US$ 25,000 Mn revenues by 2022-end. Request For Sample Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=75 The trend of using off-label drugs that are affordable and unapproved, but effective in treating diseases, has been witnessing an upsurge over the past few years. Various off-label drugs including tricyclic antidepressants, antihistamines,
OTC Drug Market Report Research : 2017
Reports And Markets Publish a New Market Research Report On –" OTC Drug Market Report Research : 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/asia-pacific-otc-drug-market-report-2017-1541262 In this report, the Asia-Pacific OTC Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several